These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 14594511

  • 1. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
    Dobo I, Pineau D, Robillard N, Geneviève F, Piard N, Zandecki M, Hermouet S.
    J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
    [Abstract] [Full Text] [Related]

  • 2. Circulating stem cell collection in lymphoma and myeloma after mobilization with cyclophosphamide and granulocyte colony-stimulating factor for autologous transplantation.
    Cancelas JA, Hernández-Jodra M, Zamora C, Perez-Oteyza J, Brieva JA, Roldan E, Navas G, Garcia-Laraña J, Lopez J, Odriozola J.
    Vox Sang; 1994 Oct; 67(4):362-7. PubMed ID: 7535498
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 5. Reproducible scoring of CFU-GM and BFU-E grown in collagen-based semisolid medium after a short (3 h) training.
    Dobo I, Bidet JM, Acquart S, Allegraud A, Amiot L, Boccaccio C, Boiret N, Domenech J, Mossuz P, Sensebe L, Wunder E, Zandecki M, Hermouet S.
    J Hematother; 1999 Feb; 8(1):45-51. PubMed ID: 10192301
    [Abstract] [Full Text] [Related]

  • 6. Plastic-adherent progenitor cells in mobilized peripheral blood progenitor cell collections.
    Scott MA, Apperley JF, Jestice HK, Bloxham DM, Marcus RE, Gordon MY.
    Blood; 1995 Dec 15; 86(12):4468-73. PubMed ID: 8541535
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Siena S, Bregni M, Brando B, Belli N, Ravagnani F, Gandola L, Stern AC, Lansdorp PM, Bonadonna G, Gianni AM.
    Blood; 1991 Jan 15; 77(2):400-9. PubMed ID: 1702334
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.
    Bone Marrow Transplant; 1998 Mar 15; 21(6):561-8. PubMed ID: 9543059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET, Towery JA, Miller AN, Kramer C, Hogan KR, Squires JE, Stuart RK, Costa LJ.
    Transfusion; 2011 Sep 15; 51(9):1995-2000. PubMed ID: 21392017
    [Abstract] [Full Text] [Related]

  • 14. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar 15; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 15. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK, Imrie K, Keating A, Anania S, Nayar R, Sutherland DR.
    Exp Hematol; 1995 Dec 15; 23(14):1619-27. PubMed ID: 8542956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma.
    Zimmerman TM, Michelson GC, Mick R, Grinblatt DL, Williams SF.
    J Clin Apher; 1999 Dec 15; 14(1):31-4. PubMed ID: 10355661
    [Abstract] [Full Text] [Related]

  • 18. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S, Karakus E, Kaynar L, Kurnaz F, Pala C, Keklik M, Zararsiz G, Solmaz M, Eser B, Cetin M, Unal A.
    Transfus Apher Sci; 2013 Jun 15; 48(3):315-20. PubMed ID: 23611684
    [Abstract] [Full Text] [Related]

  • 19. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF.
    Benboubker L, Domenech J, Linassier C, Desbois I, Delain M, Lamagnere JP, Colombat P, Binet C.
    Exp Hematol; 1995 Dec 15; 23(14):1568-73. PubMed ID: 8542948
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.